NCT02323256

Brief Summary

This study aims at investigating new automatic fitting techniques for cochlear implant patients based on objective measures. For this reason, the evolution of these neurophysiological measures, expressing the encoding of pure tones and speech, will be characterized in cochlear implanted patients as a function of post-implantation time and will be compared to those of normal hearing subjects. Moreover, the effect of auditory training with new tools based on serious games will be assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
91

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2014

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 15, 2014

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 23, 2014

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2018

Completed
Last Updated

August 11, 2025

Status Verified

August 1, 2025

Enrollment Period

3.8 years

First QC Date

October 15, 2014

Last Update Submit

August 8, 2025

Conditions

Keywords

cochlear implantdeafnessaudiometryspeech perceptionsevere to profound deafness restored with cochlear implantation

Outcome Measures

Primary Outcomes (8)

  • Amplitude of auditory steady state responses ASSR

    one year at least after CI activation

  • Spectro-temporal analysis of speech-ABR

    one year at least after CI activation

  • Acoustic Change Complex ACC

    Amplitudes and latencies of ACC

    one year at least after CI activation

  • amplitudes and latencies of P1/N1/P2 complex and Mismatch Negativity MMN

    one year at least after CI activation

  • Evolution of amplitude of auditory steady state responses ASSR

    Evolution of ASSR amplitudes as a function of time during the first year of CI activation in newly implanted patients

    1 month, 3 months, 6 months, 9 months and 12 months after CI activation

  • Evolution of spectro-temporal analysis of speech-ABR

    Evolution of spectro-temporal analysis of speech-ABR as a function of time during the first year of CI activation in newly implanted patients

    1 month, 3 months, 6 months, 9 months and 12 months after CI activation

  • Acoustic Change Complex ACC

    Evolution of amplitudes and latencies of ACC as a function of time during the first year of CI activation in newly implanted patients

    1 month, 3 months, 6 months, 9 months and 12 months after CI activation

  • amplitudes and latencies of P1/N1/P2 complex and Mismatch Negativity MMN

    Evolution of amplitudes and latencies of P1N1P2 and MMN as a function of time during the first year of CI activation in newly implanted patients

    1 month, 3 months, 6 months, 9 months and 12 months after CI activation

Study Arms (4)

newly cochlear implanted adult patients

EXPERIMENTAL

longitudinal group

Other: Auditory steady-state response ASSROther: Speech-ABROther: Acoustic Change Complex ACCOther: P1-N1-P2 complex and Mismatch Negativity MMN

newly cochlear implanted children

EXPERIMENTAL

longitudinal group

Other: Auditory steady-state response ASSROther: Speech-ABROther: Acoustic Change Complex ACCOther: P1-N1-P2 complex and Mismatch Negativity MMN

cochlear implanted adult patients (CI>1 year)

ACTIVE COMPARATOR

transversal group

Other: Auditory steady-state response ASSROther: Speech-ABROther: Acoustic Change Complex ACCOther: P1-N1-P2 complex and Mismatch Negativity MMN

normal hearing adult subjects

ACTIVE COMPARATOR

transversal group

Other: Auditory steady-state response ASSROther: Speech-ABROther: Acoustic Change Complex ACCOther: P1-N1-P2 complex and Mismatch Negativity MMN

Interventions

comparison of ASSR amplitudes in response to amplitude-modulated sounds delivered at different intensities

cochlear implanted adult patients (CI>1 year)newly cochlear implanted adult patientsnewly cochlear implanted childrennormal hearing adult subjects
Also known as: comparison of spectro-temporal analysis of speech-ABR generated in response to speech syllables
cochlear implanted adult patients (CI>1 year)newly cochlear implanted adult patientsnewly cochlear implanted childrennormal hearing adult subjects

comparison of ACC complex in response to changes within speech stimulation

cochlear implanted adult patients (CI>1 year)newly cochlear implanted adult patientsnewly cochlear implanted childrennormal hearing adult subjects

comparison of amplitudes and latencies of P1-N1-P2 complex and MMN generated in response to the detection of changes in a series of auditory stimulation

cochlear implanted adult patients (CI>1 year)newly cochlear implanted adult patientsnewly cochlear implanted childrennormal hearing adult subjects

Eligibility Criteria

Age1 Year - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • native French speaker
  • no medical treatment for behavior or neurological disorders
  • normal or corrected vision
  • right-handed
  • normal ORL examination
  • valid affiliation to social security
  • absence of participation to another study
  • For the cochlear implanted patients:
  • aged from 1 to 70
  • bilateral severe to profound deafness
  • cochlear implant
  • congenital deafness, pre or post lingual
  • For the normal-hearing subjects:
  • Aged from 18 to 70
  • Normal tonal audiometry

You may not qualify if:

  • No signed consent
  • Treatment for depression, epilepsy, Parkinson's or Alzheimer's disease
  • Physical health deficiency
  • Mental retardation
  • Neurological or psychiatric disease incompatible with the testing procedure
  • Schooling in a foreign language
  • Foreign language spoken at home with both parents
  • Invalid social security
  • For the normal hearing subjects, no known hearing deficits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospices Civils de Lyon - Hopital Edouard Herriot

Lyon, 69003, France

Location

Related Publications (1)

  • Attina V, Mina F, Stahl P, Duroc Y, Veuillet E, Truy E, Thai-Van H. A New Method to Test the Efficiency of Cochlear Implant Artifacts Removal From Auditory Evoked Potentials. IEEE Trans Neural Syst Rehabil Eng. 2017 Dec;25(12):2453-2460. doi: 10.1109/TNSRE.2017.2723952. Epub 2017 Jul 6.

MeSH Terms

Conditions

Deafness

Condition Hierarchy (Ancestors)

Hearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 15, 2014

First Posted

December 23, 2014

Study Start

July 1, 2014

Primary Completion

May 1, 2018

Study Completion

May 1, 2018

Last Updated

August 11, 2025

Record last verified: 2025-08

Locations